Tarangini Deshpande

Tarangini (Gini) Deshpande is a distinguished professional in the biomedicine sector, currently serving as a Member of the Board of Directors at Kojin Therapeutics since December 2021 and as a Venture Partner at Cathay Capital since January 2021. As the Founder and CEO of NuMedii since July 2008, Tarangini has demonstrated a strong entrepreneurial spirit. Previous experience includes roles as a Consultant at 5River Biomed Consulting (March 2007 - August 2008), Senior Manager of Strategic Marketing and Market Development at Affymetrix, Inc. (September 2005 - January 2007), Director of the Pediatric Product Development Initiative, and Licensing Manager at Children's Hospital Boston (2001 - 2005). Early career experience includes a Postdoctoral Fellowship at Massachusetts General Hospital (2000 - 2001). Tarangini holds a Ph.D. in Biological Sciences from Purdue University (1994 - 2000) and an M.Sc. from Savitribai Phule Pune University (1991 - 1994).